Campbell & CO Investment Adviser LLC Takes Position in Mettler-Toledo International, Inc. $MTD

Campbell & CO Investment Adviser LLC acquired a new position in Mettler-Toledo International, Inc. (NYSE:MTD) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,800 shares of the medical instruments supplier’s stock, valued at approximately $2,210,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Procyon Advisors LLC grew its position in shares of Mettler-Toledo International by 77.5% during the 3rd quarter. Procyon Advisors LLC now owns 877 shares of the medical instruments supplier’s stock worth $1,077,000 after buying an additional 383 shares during the period. Versant Capital Management Inc lifted its holdings in Mettler-Toledo International by 42.1% in the third quarter. Versant Capital Management Inc now owns 27 shares of the medical instruments supplier’s stock valued at $33,000 after buying an additional 8 shares during the period. PKO Investment Management Joint Stock Co bought a new position in Mettler-Toledo International in the third quarter valued at approximately $368,000. Nordea Investment Management AB grew its holdings in Mettler-Toledo International by 10.2% during the 3rd quarter. Nordea Investment Management AB now owns 140,680 shares of the medical instruments supplier’s stock worth $167,419,000 after acquiring an additional 13,056 shares during the period. Finally, Tokio Marine Asset Management Co. Ltd. raised its position in shares of Mettler-Toledo International by 7.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 727 shares of the medical instruments supplier’s stock valued at $892,000 after acquiring an additional 49 shares during the last quarter. 95.07% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Mettler-Toledo International news, CFO Shawn Vadala sold 1,000 shares of Mettler-Toledo International stock in a transaction dated Tuesday, November 25th. The stock was sold at an average price of $1,511.00, for a total value of $1,511,000.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,990,168. This trade represents a 15.90% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Elisha W. Finney sold 474 shares of the business’s stock in a transaction dated Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the completion of the sale, the director owned 311 shares in the company, valued at approximately $445,840.27. This trade represents a 60.38% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 in the last ninety days. 1.94% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

MTD has been the topic of several recent research reports. Bank of America upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,600.00 price target on the stock in a research report on Monday, December 15th. Evercore ISI raised their target price on Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Wall Street Zen lowered Mettler-Toledo International from a “buy” rating to a “hold” rating in a research report on Sunday, January 11th. Citigroup increased their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, Barclays decreased their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a report on Monday, December 15th. Six research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $1,441.67.

Mettler-Toledo International Stock Performance

Shares of MTD opened at $1,457.91 on Friday. The stock has a 50 day simple moving average of $1,432.83 and a 200 day simple moving average of $1,337.57. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,525.17. The firm has a market capitalization of $29.79 billion, a PE ratio of 36.36, a P/E/G ratio of 4.45 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share for the quarter, beating analysts’ consensus estimates of $10.62 by $0.53. The firm had revenue of $1.03 billion for the quarter, compared to analyst estimates of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business’s revenue was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 EPS for the current fiscal year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.